Mesa Laboratories investors back board, pay

Mesa Laboratories’ 2026 annual meeting saw all director nominees elected and shareholders approving auditor ratification and executive compensation.

Rhea-AI Filing Summary

MESA LABORATORIES, INC. (MLAB) reported the results of its September 8, 2026 annual meeting of shareholders. Holders of 5,595,869 common shares were entitled to vote, and 4,872,692 shares were represented in person or by proxy.

All seven director nominees — John Sullivan, Siddhartha Kadia, Shiraz Ladiwala, Jennifer “Jenny” Alltoft, Mark Capone, Shannon Hall, and R. Tony Tripeny — were elected to one-year terms, each receiving over 4.35 million votes in favor, with broker non-votes recorded. Shareholders also approved the ratification of Baker Tilly US, LLP as independent registered public accounting firm for the fiscal year ending March 31, 2027, with 4,814,383 votes for. On a non-binding advisory basis, shareholders approved the compensation of the named executive officers, with 4,317,389 votes for and 136,782 against.

8-K Event Classification

Item 5.07 — Submission of Matters to a Vote of Security Holders

1 item

Item 5.07 Submission of Matters to a Vote of Security Holders Governance

Results of a shareholder vote on proposals at an annual or special meeting.

Key Figures

Shares entitled to vote: 5,595,869 shares Shares represented at meeting: 4,872,692 shares Votes for highest-supported director: 4,421,045 votes +5 more

8 metrics

Shares entitled to vote 5,595,869 shares Common stock entitled to vote at the September 8, 2026 annual meeting

Shares represented at meeting 4,872,692 shares Shares present in person or by proxy at the annual meeting

Votes for highest-supported director 4,421,045 votes Votes for director nominee Siddhartha Kadia

Votes for auditor ratification 4,814,383 votes For ratification of Baker Tilly US, LLP for fiscal year ending March 31, 2027

Votes against auditor ratification 56,778 votes Against ratification of Baker Tilly US, LLP

Say-on-pay votes for 4,317,389 votes For non-binding advisory approval of named executive officer compensation

Say-on-pay votes against 136,782 votes Against non-binding advisory approval of executive compensation

Broker non-votes on say-on-pay 338,195 votes Broker non-votes on the advisory vote on executive compensation

Key Terms

broker non-votes, independent registered public accounting firm, non-binding advisory basis, named executive officers

4 terms

broker non-votes financial

"withheld, and 338,195 broker non-votes"

Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.

independent registered public accounting firm financial

"to serve as the Company’s independent registered public accounting firm"

An independent registered public accounting firm is an outside accounting company officially registered with the government regulator to examine and report on a public company's financial records and controls. Investors treat its reports like an impartial inspector’s certificate — they add credibility to financial statements, help spot errors or misleading claims, and reduce the risk that shareholders are relying on unchecked or biased numbers.

non-binding advisory basis financial

"was approved on a non-binding advisory basis"

A non-binding advisory basis is guidance or a recommendation offered for informational purposes that does not create legal obligations or guarantees; recipients can accept, modify, or ignore it without contractual consequences. Investors should treat it like a weather forecast for planning—useful for forming expectations and assessing risk, but not a firm promise—so they should verify assumptions, seek confirming information, and avoid relying on it as the sole basis for investment decisions.

named executive officers financial

"compensation of the Company’s named executive officers"

Named executive officers are the senior company leaders whose names, roles and compensation are singled out in required regulatory filings; this typically includes the chief executive, chief financial officer and the next highest‑paid senior officers. Investors treat this list like a team roster — it shows who makes key decisions, how they are paid and whether incentives align with shareholder interests, so changes or pay patterns can signal governance quality, risk or strategic shifts.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What matters did MLAB shareholders vote on at the September 8, 2026 annual meeting?

Shareholders voted on three proposals: election of seven directors to one-year terms, ratification of Baker Tilly US, LLP as independent registered public accounting firm for the fiscal year ending March 31, 2027, and a non-binding advisory vote on executive compensation.

How many Mesa Laboratories (MLAB) shares were represented at the 2026 annual meeting?

Holders of 5,595,869 Mesa Laboratories common shares were entitled to vote, and 4,872,692 shares were represented in person or by proxy at the annual meeting on September 8, 2026.

Were all Mesa Laboratories (MLAB) director nominees elected in 2026?

Yes. All seven nominees were elected. For example, John Sullivan received 4,388,976 votes for and 145,521 withheld, while R. Tony Tripeny received 4,352,734 votes for and 181,763 withheld, each with 338,195 broker non-votes.

Did Mesa Laboratories (MLAB) shareholders approve the auditor for fiscal 2027?

Yes. Shareholders approved Baker Tilly US, LLP as the independent registered public accounting firm for the fiscal year ending March 31, 2027, with 4,814,383 votes for, 56,778 against, and 1,531 abstentions.

How did Mesa Laboratories (MLAB) shareholders vote on executive compensation in 2026?

On a non-binding advisory basis, shareholders approved the compensation of the named executive officers with 4,317,389 votes for, 136,782 against, 80,326 abstentions, and 338,195 broker non-votes.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/08/2026 - 03:27 PM Accepted by SEC EDGAR 09/08/2026 - 03:26 PM Learn about SEC filing dates

false 0000724004 0000724004 2026-09-08 2026-09-08

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549   

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): September 8, 2026

MESA LABORATORIES, INC. 
(Exact name of registrant as specified in its charter)

Colorado 
(State or other jurisdiction of
incorporation) 0-11740 (Commission File  Number) 84-0872291 
(I.R.S. Employer
Identification No.)

12100 WEST SIXTH AVENUE, LAKEWOOD, Colorado 
(Address of principal executive offices) 80228 

(Zip Code)

Registrant’s telephone number, including area code: 303-987-8000

Not Applicable  
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered under Section 12(b) of the Act:

Title of each class		Trading Symbol		Name of each exchange on which registered
Common Stock, no par value		MLAB		The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

ITEM 5.07          SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

On September 8, 2026, the Company held its annual meeting of shareholders (the “Annual Meeting”). Holders of 5,595,869 shares of Mesa’s common stock were entitled to vote, of which 4,872,692 shares were represented in person or by proxy at the Annual Meeting.

The certified results of the matters voted upon at the Annual Meeting, which are more fully described in the Company’s proxy statement for the Annual Meeting, are as follows:

Proposal 1 – Election of directors

Each of John Sullivan, Siddhartha Kadia, Shiraz Ladiwala, Jennifer “Jenny” Alltoft, Mark Capone, Shannon Hall, and R. Tony Tripeny was elected to the Board of Directors of Mesa to hold office for a one-year term, until the 2027 annual meeting of shareholders:

​

​

For

​

​

Withheld

​

​

Broker Non-Votes

​

John Sullivan, Ph.D.

​

​

4,388,976

​

​

​

145,521

​

​

​

338,195

​

Siddhartha Kadia, Ph.D.

​

​

4,421,045

​

​

​

113,452

​

​

​

338,195

​

Shiraz Ladiwala

​

​

4,402,912

​

​

​

131,585

​

​

​

338,195

​

Jenny Alltoft

​

​

4,395,928

​

​

​

138,569

​

​

​

338,195

​

Mark Capone

​

​

4,405,110

​

​

​

129,387

​

​

​

338,195

​

Shannon Hall

​

​

4,399,078

​

​

​

135,419

​

​

​

338,195

​

R. Tony Tripeny

​

​

4,352,734

​

​

​

181,763

​

​

​

338,195

​

Proposal 2 – Ratification of the selection by our Audit Committee of Baker Tilly US, LLP to serve as the Company’s independent registered public accounting firm for the fiscal year ending March 31, 2027

The appointment of Baker Tilly US, LLP as the Company’s independent registered public accounting firm for the fiscal year ending March 31, 2027 was approved:

For		Against		Abstain		Broker  Non-Votes
4,814,383		56,778		1,531		-

Proposal 3 – Approval on a non-binding basis of the compensation of the Company's named executive officers

The compensation of the Company’s named executive officers, as disclosed in the proxy statement, was approved on a non-binding advisory basis:

For		Against		Abstain		Broker  Non-Votes
4,317,389		136,782		80,326		338,195

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

DATE: September 8, 2026		Mesa Laboratories, Inc.
		(Registrant)
	BY:	/s/ John Sakys
		John Sakys
		Chief Financial Officer

Filing Exhibits & Attachments

4 documents

Other Documents

• EX-101 XBRL TAXONOMY EXTENSION SCHEMA 3.5 KB
• EX-101 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE 11.2 KB
• EX-101 XBRL TAXONOMY EXTENSION LABEL LINKBASE 15.0 KB
• EX-101 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE 11.3 KB